1-20 of 54
Javier Bolaños-Meade
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Large-Scale Post-Transplant TCR Deep Sequencing Reveals a Major T Cell Diversity Bottleneck with Post-Transplant Cyclophosphamide with Implications for Both Efficacy and Toxicity: Results of the BMT CTN 1801 Study

Leslie Kean, Steven J Siegel, Joseph T Schmalz, Stephanie A Bien, Danielle Scheffey, Catherine Sanders, Harlan Robins, Kristy Applegate, Merav Bar, Saurabh Chhabra, Sung W. Choi, William Clark, Suman r Das, Robert R. Jenq, Richard J. Jones, John Levine, Brent R. Logan, Hemant S. Murthy, Armin Rashidi, Marcie L. Riches, Wael Saber, Karamjeet S. Sandhu, Anthony D. Sung, Karilyn Larkin, Monzr M. Al Malki, Mahasweta Gooptu, Hany Elmariah, Amin Alousi, Lyndsey Runaas, Brian C. Shaffer, Andrew R. Rezvani, Najla El Jurdi, Alison Loren, Mary M. Horowitz, Javier Bolanos-Meade, Shernan G. Holtan, Ami S. Bhatt, Miguel-Angel Perales, Susan DeWolf
Journal: Blood
Blood (2023) 142 (Supplement 1): 475.
https://doi.org/10.1182/blood-2023-188032
Published: 2023
Journal Articles

A Phase IB/II Study of Blinatumomab in Patients with B-Cell Acute Lymphoblastic Leukemia (ALL) and B-Cell Non-Hodgkin Lymphoma (NHL) As Post-Allogeneic Blood or Marrow Transplant (alloBMT) Remission Maintenance

Jonathan Allen Webster, Richard J. Jones, Amanda Blackford, Audra Shedeck, Richard F. Ambinder, Lode J. Swinnen, Nina Wagner-Johnston, Ephraim Joseph Fuchs, Javier Bolanos-Meade, Philip Imus, Challice L. Bonifant, Heather Jill Symons, Tania Jain, Gabrielle T. Prince, Mark J. Levis, Leo Luznik, Ivana Gojo
Journal: Blood
Blood (2023) 142 (Supplement 1): 3582.
https://doi.org/10.1182/blood-2023-191047
Published: 2023
Journal Articles

Post-Transplant Cyclophosphamide Eliminates Disparity in GvHD-Free, Relapse-Free Survival and Overall Survival between 8/8 Matched and 7/8 Mismatched Unrelated Donor Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies

Jeffery J. Auletta, Monzr M. Al Malki, Todd DeFor, Brian C. Shaffer, Mahasweta Gooptu, Javier Bolanos-Meade, Ramzi Abboud, Adrienne D. Briggs, Farhad Khimani, Dipenkumar Modi, Richard Newcomb, Elizabeth J. Shpall, Caitrin Bupp, Stephen R. Spellman, Heather E. Stefanski, Antonio M. Jimenez Jimenez, Steven M. Devine
Journal: Blood
Blood (2023) 142 (Supplement 1): 780.
https://doi.org/10.1182/blood-2023-172722
Published: 2023
Journal Articles

Patient-Reported Outcomes of BMT CTN 1703: A Randomized Phase III Study for Gvhd Prophylaxis - a Quality of Life Evaluation

Shernan G. Holtan, Michael J Martens, Monzr M. Al Malki, Yvonne Efebera, Carrie L. Kitko, Ran Reshef, Andrew R. Rezvani, Brian C. Shaffer, Melhem M. Solh, Janny M. Yao, Lyndsey Runaas, Hany Elmariah, Karilyn T. Larkin, Najla H El Jurdi, Mahasweta Gooptu, Alison W Loren, Aric C. Hall, Amin Alousi, Omer Jamy, William Clark, Leslie Kean, Ami S. Bhatt, Miguel-Angel Perales, Kristy Applegate, Juan WU, Eric Liefer, Nancy DiFronzo, Richard J. Jones, Mary M. Horowitz, Deborah Mattila, Mehdi Hamadani, Javier Bolanos-Meade
Journal: Blood
Blood (2023) 142 (Supplement 1): 897.
https://doi.org/10.1182/blood-2023-187859
Published: 2023
Journal Articles

Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia

Clinical Trials & Observations
Amy E. DeZern, Marianna Zahurak, Heather J. Symons, Kenneth R. Cooke, Carol Ann Huff, Tania Jain, Lode J. Swinnen, Philip H. Imus, Nina D. Wagner-Johnston, Richard F. Ambinder, Mark Levis, Leo Luznik, Javier Bolaños-Meade, Ephraim J. Fuchs, Richard J. Jones, Robert A. Brodsky
Journal: Blood
Blood (2023) 141 (25): 3031–3038.
https://doi.org/10.1182/blood.2023020435
Published: 2023
Includes: Supplemental data
Journal Articles

Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil As the New Standard for Graft-Versus-Host Disease (GVHD) Prophylaxis in Reduced Intensity Conditioning: Results from Phase III BMT CTN 1703

Shernan G Holtan, Mehdi Hamadani, Juan WU, Monzr M. AL Malki, Lyndsey Runaas, Hany Elmariah, Andrew R. Rezvani, Mahasweta Gooptu, Karilyn T. Larkin, Brian C. Shaffer, Najla H El Jurdi, Alison W. Loren, Melhem Solh, Aric C. Hall, Amin M Alousi, Omer H Jamy, Miguel-Angel Perales, Janny M. Yao, Kristy Applegate, Ami S. Bhatt, Leslie S. Kean, Yvonne A. Efebera, Carrie Lynn Kitko, Ran Reshef, William Clark, Nancy L. DiFronzo, Lori Henderson, Richard J. Jones, Eric Liefer, Michael J Martens, Mary M. Horowitz, Javier Bolanos-Meade
Journal: Blood
Blood (2022) 140 (Supplement 2): LBA-4.
https://doi.org/10.1182/blood-2022-171463
Published: 2022
Journal Articles

Alternative Reduced Intensity Conditioning for Allogeneic Blood and Marrow Transplantation Using Pentostatin, Cyclophosphamide, and Total-Body Irradiation with Post-Transplant Cyclophosphamide

Timothy J. Porter, Haval Norman, Javier Bolanos-Meade, Leo Luznik, Jamie E. Ziggas, Amy E. DeZern, Ephraim J. Fuchs, Richard J. Jones
Journal: Blood
Blood (2022) 140 (Supplement 1): 7601–7602.
https://doi.org/10.1182/blood-2022-166641
Published: 2022
Journal Articles

Allogeneic Blood or Marrow Transplantation (AlloBMT) with High-Dose Post-Transplantation Cyclophosphamide (PTCy) for Acute Lymphoblastic Leukemia (ALL) in Patients Aged ≥ 55: Best Results in B ALL in First Remission (CR1) with Reduced-Intensity Conditioning (RIC)

Jonathan Allen Webster, Madison C. Reed, Hua-Ling Tsai, Alexander J. Ambinder, Tania Jain, Amy E. DeZern, Mark J. Levis, Margaret M. Showel, Gabrielle T. Prince, Christopher S. Hourigan, Javier Bolaños-Meade, Lukasz P. Gondek, Gabriel Ghiaur, William Brian Dalton, Suman Paul, Ephraim J. Fuchs, Christian B. Gocke, Abbas Abbas Ali, Douglas E. Gladstone, Carol Ann Huff, Ivan M. Borrello, Lode J. Swinnen, Nina D. Wagner-Johnston, Richard F. Ambinder, Leo Luznik, Ivana Gojo, B. Douglas Douglas Smith, Ravi Varadhan, Richard J. Jones, Philip H. Imus
Journal: Blood
Blood (2022) 140 (Supplement 1): 4813–4815.
https://doi.org/10.1182/blood-2022-171038
Published: 2022
Journal Articles

Nonmyeloablative Allogeneic Transplantation in First Remission for Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia with Post-Transplantation Cyclophosphamide: Outcomes By Receipt of Pre-Transplant Blinatumomab

Jonathan Webster, B. Douglas Smith, Amy E. DeZern, Alexander J. Ambinder, Mark Levis, Margaret M. Showel, Gabrielle T. Prince, Lukasz P. Gondek, Gabriel Ghiaur, William Brian Dalton, Christopher S. Hourigan, Tania Jain, Douglas E Gladstone, Leo Luznik, Philip H. Imus, Javier Bolanos-Meade, Ephraim J. Fuchs, Christian B. Gocke, Abbas Abbas Ali, Carol Ann Huff, Ivan M. Borrello, Lode J. Swinnen, Nina D. Wagner-Johnston, Richard F. Ambinder, Richard J. Jones, Ivana Gojo
Journal: Blood
Blood (2021) 138 (Supplement 1): 1846.
https://doi.org/10.1182/blood-2021-153750
Published: 2021
Journal Articles

MI-Immune/1801: Lessons from an Ongoing, Multi-Center Trial Involving Biospecimen Collection for Prospective Microbiome and Immune Profiling in Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT

Erin Brooks, Ashley Spahn, Stephanie Waldvogel, Alan Howard, Merav Bar, Brandi Bratrude, Saurabh Chhabra, William Clark, Suman Ranjan Das, Mary M. Horowitz, Robert R. Jenq, Richard J. Jones, John E. Levine, Brent R. Logan, Hemant S. Murthy, Armin Rashidi, Marcie L. Riches, Mary Mansour Riwes, Karamjeet S. Sandhu, Anthony D. Sung, Monzr M. Al Malki, Lyndsey Runaas, Hany Elmariah, Andrew R. Rezvani, Mahasweta Gooptu, Javier Bolaños-Meade, Shernan G Holtan, Wael Saber, Mehdi Hamadani, Leslie S Kean, Miguel-Angel Perales, Ami S. Bhatt
Journal: Blood
Blood (2021) 138 (Supplement 1): 2955.
https://doi.org/10.1182/blood-2021-149313
Published: 2021
Journal Articles

Allogeneic Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Post-Transplantation Cyclophosphamide: Assessing the Importance of Conditioning Regimen, Donor Choice, and Tyrosine Kinase Inhibitor Use

Jonathan Webster, MD, Leo Luznik, MD, Hua-Ling Tsai, ScM, Philip H. Imus, MD, Amy E. DeZern, MD, Keith W. Pratz, MD, Mark Levis, MD PhD, Ivana Gojo, MD, Margaret M. Showel, MD, Gabrielle T. Prince, MD, Javier Bolanos-Meade, MD, Lukasz P. Gondek, MDPhD, Gabriel Ghiaur, MD PhD, William Brian Dalton, MD PhD, Tania Jain, MD, Ephraim J. Fuchs, MD MBA, Douglas E Gladstone, MD, Christian B. Gocke, MD PhD, Abbas Abbas Ali, MD, Carol Ann Huff, MD, Ivan M. Borrello, MD, Lode J. Swinnen, MB ChB, Nina D. Wagner-Johnston, Richard F. Ambinder, MD, Richard J. Jones, MD, B. Douglas Smith, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 44–45.
https://doi.org/10.1182/blood-2020-141294
Published: 2020
Journal Articles

Reduced-Intensity Induction with Dasatinib Vs. Hypercvad + 2 nd Generation TKIs with MRD-Guided Follow-up Therapy Leads to Comparable Rates of MRD-Negative Remission While Reducing Transfusions and Neutropenia in Ph+ ALL

Jonathan Webster, MD, Hua-Ling Tsai, ScM, Eric Gehrie, Tania Jain, MD, Christopher S. Hourigan, MDDPhil, William Brian Dalton, MD PhD, Gabrielle T. Prince, MD, Lukasz P. Gondek, MDPhD, Gabriel Ghiaur, MD PhD, Amy E. DeZern, MD, Margaret M. Showel, MD, Ivana Gojo, MD, Douglas E Gladstone, MD, Philip H. Imus, MD, Javier Bolanos-Meade, MD, Leo Luznik, MD, Ephraim J. Fuchs, MD MBA, Christian B. Gocke, MD PhD, Abbas Abbas Ali, MD, Carol Ann Huff, MD, Ivan M. Borrello, MD, Lode J. Swinnen, MB ChB, Nina D. Wagner-Johnston, Richard F. Ambinder, MD, Richard J. Jones, MD, B. Douglas Smith, MD, Mark Levis, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–44.
https://doi.org/10.1182/blood-2020-141264
Published: 2020
Journal Articles

Bridging the Gap in Access to Transplant for Underserved Minority Patients Using Mismatched Unrelated Donors and Post-Transplant Cyclophosphamide: A National Marrow Donor Program/be the Match (NMDP/BTM) Initiative

Bronwen E. Shaw, PhD MRCP, FRCPath, Antonio Jimenez-Jimenez, MD MS, Linda J. Burns, MD, Brent Logan, PhD, Farhad Khimani, MD, Brian C. Shaffer, MD, Nirav N. Shah, MD, Alisha Mussetter, BS, ACRP-CP, Xiao-Ying Tang, MPH, John M McCarty, MD, Asif Alavi, MD, Nosha Farhadfar, MD, Katarzyna Jamieson, MD, Nancy M. Hardy, MD, Hannah Choe, MD, Richard F. Ambinder, MD, Claudio Anasetti, MD, Miguel-Angel Perales, MD, Alan Howard, PhD, Krishna V Komanduri, MD, Leo Luznik, MD, Maxim Norkin, MD PhD, Joseph Pidala, MD, Voravit Ratanatharathorn, MD, Dennis L. Confer, MD, Steven M Devine, MD, Mary M. Horowitz, MD MS, Javier Bolanos-Meade, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 48–49.
https://doi.org/10.1182/blood-2020-137677
Published: 2020
Journal Articles

Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial

Clinical Trials & Observations
Joseph Pidala, Mehdi Hamadani, Peter Dawson, Michael Martens, Amin M. Alousi, Madan Jagasia, Yvonne A. Efebera, Saurabh Chhabra, Iskra Pusic, Shernan G. Holtan, James L. M. Ferrara, John E. Levine, Marco Mielcarek, Claudio Anasetti, Joseph H. Antin, Javier Bolaños-Meade, Alan Howard, Brent R. Logan, Eric S. Leifer, Theresa S. Pritchard, Mary M. Horowitz, Margaret L. MacMillan
Journal: Blood
Blood (2020) 135 (2): 97–107.
https://doi.org/10.1182/blood.2019003125
Published: 2020
Includes: Supplemental data
Journal Articles

Making Progress in Graft-Versus-Host Disease Prophylaxis and Microbiome Analysis in the Blood and Marrow Transplant Clinical Trials Network: Progress III (1703)/MI-Immune (1801)

Shernan Holtan, MD, Ami S. Bhatt, MD PhD, Raphael Fraser, PhD, Miguel-Angel Perales, MD, Leslie Kean, MD PhD, Wael Saber, MD MS, Mehdi Hamadani, MD, Brent R. Logan, Javier Bolaños-Meade, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2005.
https://doi.org/10.1182/blood-2019-122782
Published: 2019
Journal Articles

Shortened Immunosuppression Following Peripheral Blood (PB) Haploidentical (haplo) Transplantation with Post-Transplant Cyclophosphamide (PTCy) Is Associated with Tolerable Rates of Graft-Vs-Host Disease (GVHD)

Amy E. DeZern, MD, Marianna Zahurak, MS, Javier Bolanos-Meade, MD, Richard J. Jones, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3320.
https://doi.org/10.1182/blood-2019-122762
Published: 2019
Journal Articles

Allogeneic Transplantation for Myelodysplastic Syndrome in Adults over 50 Years Old Using Reduced Intensity/Non-Myeloablative Conditioning: Haploidentical Relative Versus Matched Unrelated Donor

Michael R. Grunwald, MD, Mei-Jie Zhang, Hany Elmariah, MDMS, Mariam H Johnson, MPH, Andrew St. Martin, MS, Asad Bashey, MD PhD, Javier Bolanos-Meade, MD, Christopher Bredeson, MDFRCPC,MSc, Edward A Copelan, Biju George, MDDM, Vikas Gupta, MD FRCP, FRCPath, Christopher G. Kanakry, MD, Rohtesh S. Mehta, MD, Minoo Battiwalla, MD, Alberto Mussetti, Ryotaro Nakamura, MD, Taiga Nishihori, MD, Wael Saber, MD MS, Melhem Solh, MD, Benjamin K. Tomlinson, MD, Daniel J. Weisdorf, MD, Mary Eapen, MBBS, MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 3323.
https://doi.org/10.1182/blood-2019-125865
Published: 2019
Journal Articles

T-Replete Haploidentical Cell Transplantation Using Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome: Effect of Transplant Conditioning Regimen Intensity on Outcomes

Scott R Solomon, MD, Andrew St. Martin, MS, Nirav N Shah, MD, Giancarlo Fatobene, MD, Monzr Al Malki, MD, Karen K. Ballen, MD, Asad Bashey, MD PhD, Nelli Bejanyan, MD, Javier Bolaños-Meade, MD, Claudio G Brunstein, MD PhD, Zachariah Defilipp, MD, Richard E Champlin, MD, Ephraim J. Fuchs, MD MBA, Mehdi Hamadani, MD, Peiman Hematti, MD, Christopher G. Kanakry, MD, Joseph P. McGuirk, DO, Ian K. McNiece, PhD, Stefan O. Ciurea, Marcelo C. Pasquini, MD, Vanderson Rocha, MD PhD, Rizwan Romee, MD, Sagar S. Patel, MD, Sumithira Vasu, MDMBBS, Edmund K. Waller, MD, John R. Wingard, MD, Mei-Jie Zhang, PhD, Mary Eapen, MBBS, MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 1015.
https://doi.org/10.1182/blood-2018-99-110814
Published: 2018
Journal Articles

Amphiregulin Improves Stratification of the Refined Minnesota Acute Graft-Versus-Host Disease Risk Score: Results from BMT CTN 0302/0802

Shernan G. Holtan, MD, Todd E. DeFor, MS, Joseph Pidala, MD PhD, Nandita Khera, MD, Stephanie J. Lee, MD PhD, Alan Howard, PhD, Juan Wu, F Javier Bolanos-Meade, MD, Vincent T Ho, MD, Amin M. Alousi, MD, Yoshihiri Inamoto, MD, George Chen, MD, Mukta Arora, MD, Jeanne Palmer, MD, Mary E. Flowers, MD, Corey S. Cutler, MD MPH, Alexander Lukez, Sally Arai, MD, Aleksandr Lazaryan, MD PhD MPH, Laura F. Newell, MD, Madan Jagasia, MD MBBS, MS, Iskra Pusic, MD, Sebastian A. Mayer, MD, William A. Wood, MD MPH, Anne Renteria, MD, William J. Hogan, MBBCh, Elizabeth Hexner, MDMS, Francis A Ayuk, Ernst Holler, MD, Yvonne A Efebera, MD, Rangsima Reantragoon, Hien Duong, MD, Gregory Yanik, MD, James L Ferrara, John E Levine, MD, Bruce Blazar, MD, Angela Panoskaltsis-Mortari, PhD, Daniel J. Weisdorf, MD, Margaret L. MacMillan, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 72.
https://doi.org/10.1182/blood.V130.Suppl_1.72.72
Published: 2017
Journal Articles

FLT3 ITD AML Outcomes Are Impacted By Exposure to One Cycle of Cytarabine Based Consolidation, Pre- and Post-Transplant TKI Therapy, and Presence of Minimal Residual Disease (MRD) Prior to Allogeneic Blood or Marrow Transplant

Melanie Rebechi, Amy E. DeZern, MD, Amanda Kagan, MD, B. Douglas Smith, MD, Ivana Gojo, MD, Margaret M. Showel, MD, Gabrielle T. Prince, MD, Gabriel Ghiaur, MD PhD, Lukasz P. Gondek, MD PhD, William Matsui, MD, Ephraim J. Fuchs, MD MBA, Leo Luznik, MD, Shannon R. McCurdy, MD, Carol Ann Huff, MD, Lode J. Swinnen, Ivan M. Borrello, MD, Douglas E. Gladstone, MD, Javier Bolanos-Meade, MD, Richard F Ambinder, MD, Richard J. Jones, MD, Mark J. Levis, MD, Keith Pratz, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2593.
https://doi.org/10.1182/blood.V130.Suppl_1.2593.2593
Published: 2017